Search - Prime Therapeutics
Navigate to
-
Build healthier communities By delivering affordable, reliable services that help improve health outcomes and coordinate care, we help you get your members the resources they need to live healthier...
-
Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Event features discussions about health care industry trends, best practices and innovations
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Hero headline Forward copy that anchors in the key themes of our campaign: we are an organization you can trust, with solutions built for every plan, and people who will work to do what is right...
-
Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs
PA Sub-Categories: Technology Prime Article: Perspectives -
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
-
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Prime Article: Stories -
Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...
-
Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...
-
A look at the specialty landscape and how Prime delivers value to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...
-
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives -
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...
-
publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...
-
Managed Markets Insight & Technology (MMIT)
PA Sub-Categories: Specialty drugs Products Prime Article: In the News -
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...